Amprion Newsroom
Recent media coverage and announcements.
Press Release
Business Wire
Amprion Announces Strategic Growth Initiatives, Expanding Access to Breakthrough SAAmplify Test
July 23, 2025
Read MoreNews Article
Technology Networks
Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024
8/1/2024
Read MorePress Release
PR Newswire
Amprion's αSyn Seed Amplification Assay (αS-SAA) Highlighted in 10 Presentations at AD/PD™ 2024 International Conference
3/4/2024
Read MoreVideo
Neurology Live
Revolutionizing Multiple System Atrophy Diagnosis With Amprion's Synuclein Seed Amplification Assay: Russell Lebovitz MD PhD
12/18/2024
Read MoreVideo
Neurology Live
Detecting Parkinson Disease at Early Stages With Alpha-Synuclein Amplification Assay: Russell Lebovitz MD PhD
5/11/2023
Read MorePress Release
Mayo Clinic Laboratories News
Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnostics
3/26/2025
Read MorePress Release
Businesswire
Amprion Honored to Win the 2024 BioTech Breakthrough Award 'Clinical Diagnostics Solution of the Year'
11/19/2024
Read MorePress Release
Businesswire
Amprion Announces Landmark Study in The Lancet Neurology
11/21/2024
Read MorePress Release
PR Web
SYNTap Biomarker Test helps doctors distinguish Parkinson's Disease from Parkinsonism in early stages
4/6/2022
Read MorePress Release
PR Newswire
New Paper Published in Alzheimer's: Dementia: The Journal of the Alzheimer's Association Demonstrates Correlation Between the Presence of Misfolded α-Synuclein and Clinical Presentations of Alzheimer's Disease
2/9/2024
Read MorePress Release
PR Web
New Insights On Alzheimer's And What It Means For Personalized Medicine
1/19/2022
Read MorePress Release
PR Newswire
Amprion's αSynuclein Seed Amplification Assay to be Showcased at Alzheimer's Association International Conference® 2023 (AAIC®)
7/15/2023
Read MorePress Release
Business Wire
FDA Issues Letter of Support for α-Synuclein Seed Amplification Assay – The Core Technology Used in Amprion's First Commercial Test
9/5/2024
Read MorePress Release
PR Newswire
Michael J. Fox Foundation Funds Projects to Speed Development of Quantitative Biomarkers for Parkinson's Disease
5/30/2024
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-É‘SYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
